About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Pilot Study of 18F-FLT PET

NCT00585741·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

University of Wisconsin, Madison

Age

18–any

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Able to tolerate a PET/CT scan
Age of 18 or older
signed informed consent
being considered for radiotherapy for treatment of CNS mets, Head and neck cancer, lung cancer, prostate cancer or esophageal cancer

You may not be if

Prior XRT to site being studied
severe claustrophobia or inability to tolerate PET/CT
unable to provide written consent
pregnant or breastfeeding women

The record

StatusTerminated

PhaseNo phase

Taking part15

StartedDec 2006

UpdatedFeb 23, 2012

Conditions

CNS Brain Metastasis Head and Neck Cancer Lung Cancer Prostate Cancer Esophageal Cancer

Where1

University of Wisconsin Hospital and clinis
Madison, Wisconsin, United States

Clareo Health | Pilot Study of 18F-FLT PET